Trade

with

Amgen Inc
(NASDAQ: AMGN)
US Markets Closed
AdChoices
144.09
+6.58
+4.79%
After Hours :
143.44
-0.65
-0.45%

Open

138.25

Previous Close

137.51

Volume (Avg)

8.95M (3.54M)

Day's Range

137.01-145.49

52Wk Range

108.20-145.49

Market Cap.

109.45B

Dividend Rate (Yield )

2.44 (1.60%)

Beta

0.54

Shares Outstanding

759.61M

P/E Ratio (EPS)

22.08 (6.53)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 18.68B

    • Net Income

    • 5.08B

    • Market Cap.

    • 109.45B

    • Enterprise Value

    • 111.59B

    • Net Profit Margin %

    • 25.74

    • PEG (Price/Earnings Growth) Ratio

    • 1.55

    • Beta

    • 0.54

    • Forward P/E

    • 16.00

    • Price/Sales

    • 5.68

    • Price/Book Value

    • 4.49

    • Price/Cash flow

    • 14.62

      • EBITDA

      • 7.15B

      • Return on Capital %

      • 8.20

      • Return on Equity %

      • 22.27

      • Return on Assets %

      • 8.20

      • Book Value/Share

      • 32.10

      • Shares Outstanding

      • 759.61M

      • Last Split Factor (Date)

      • 2:1 (11/22/1999)

      • Last Dividend (Ex-Date)

      • 0.61 (11/10/2014)

      • Dividend Declaration Date

      • 10/17/2014

      Analyst Recommendation
      10/20/2014
      Outperform
        • 1 Year Price Target

        • 147.00

        • Credit Rating

        • A

        • Analysts

        • 7

        • EPS Estimate

        • 7.61

        • Cashflow Estimate

        • 10.25

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 10.70

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • 16.90

          • 17.04

          • Net Income

            Q/Q (last year)

          • 23.00

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 4.48

          • 63.43

          • Net Income

            5-Year Annual Average

          • 3.90

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 79.51

            • 82.75

            • Pre-Tax Margin

            • 28.16

            • 39.38

            • Net Profit Margin

            • 25.74

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 84.10

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 30.90

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • 27.60

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 1.26

              • 0.76

              • Current Ratio

              • 4.36

              • 2.92

              • Quick Ratio

              • 3.67

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 2.85

              • 2.21

              • Book Value/Share

              • 32.10

              • 4.76

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 20.49

                • 196.08

                • P/E Ratio 5-Year High

                • 22.12

                • 634.30

                • P/E Ratio 5-Year Low

                • 7.30

                • 124.82

                • Price/Sales Ratio

                • 5.27

                • 9.12

                • Price/Book Value

                • 4.16

                • 8.26

                • Price/Cash Flow Ratio

                • 14.62

                • 47.39

                • Key Metrics

                • Company

                  • Shares Short

                    as of 9/30/2014

                  • 10.98M

                  • Short Ratio

                    as of 9/30/2014

                  • 3.71

                  • Short % of Float

                    as of 9/30/2014

                  • 1.62

                  • Shares Short

                    prior month

                  • 12.17M

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • 33.07

                    • Dividend Date

                    • 10/17/2014

                    • Ex-Dividend Date

                    • 11/10/2014

                    • Last Split Factor

                      new per old

                    • 2:1

                    • Last Split Date

                    • 11/22/1999

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 22.27

                        (21.20)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • 8.20

                        (9.60)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • 9.80

                        (10.10)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • 250.45k

                      • 117.08k

                      • Inventory Turnover

                      • 1.39

                      • 1.48

                      • Asset Turnover

                      • 0.32

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      5.87B
                      Operating Margin
                      31.41
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      14.62
                      Ownership

                      Institutional Ownership

                      83.65%

                      Top 10 Institutions

                      40.06%

                      Mutual Fund Ownership

                      50.87%

                      Float

                      89.68%

                      5% / Insider Ownership

                      0.29%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • VA CollegeAmerica Invmt Co of America

                      •  

                        22,570,703

                      • 0.00

                      • 2.97

                      • VA CollegeAmerica Cap World Gr and Inc

                      •  

                        20,167,700

                      • 0.00

                      • 2.66

                      • Vanguard PrimeCap Fund

                      •  

                        15,917,400

                      • -0.19

                      • 2.10

                      • VA CollegeAmerica Growth Fund of America

                      •  

                        13,911,100

                      • 0.00

                      • 1.83

                      • Vanguard Total Stock Mkt Idx

                      •  

                        12,423,439

                      • 1.15

                      • 1.64

                      • VA CollegeAmerica Cap Income Builder

                      •  

                        12,146,909

                      • 0.00

                      • 1.60

                      • VA CollegeAmerica American Mutual

                      •  

                        8,475,748

                      • 0.00

                      • 1.12

                      • Vanguard Health Care Fund

                      •  

                        8,049,455

                      • -2.00

                      • 1.06

                      • VA CollegeAmerica AMCAP

                      •  

                        7,977,420

                      • 3.63

                      • 1.05

                      • Vanguard Five Hundred Index Fund

                      •  

                        7,886,122

                      • 0.58

                      • 1.04

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Capital Research Global Investors

                      •  

                        92,734,872

                      • +12.38%

                      • 12.21

                      • Vanguard Group, Inc.

                      •  

                        38,574,841

                      • +1.52%

                      • 5.08

                      • Fidelity Management and Research Company

                      •  

                        37,201,633

                      • -25.48%

                      • 4.90

                      • PRIMECAP Management Company

                      •  

                        31,853,844

                      • -0.96%

                      • 4.19

                      • State Street Corp

                      •  

                        31,473,382

                      • +3.55%

                      • 4.14

                      • BlackRock Fund Advisors

                      •  

                        23,952,114

                      • +0.60%

                      • 3.15

                      • Wellington Management Company, LLP

                      •  

                        18,001,256

                      • -5.78%

                      • 2.37

                      • ClearBridge Advisors, LLC

                      •  

                        11,083,003

                      • +21.52%

                      • 1.46

                      • Northern Trust Investments, N.A.

                      •  

                        11,035,499

                      • +0.08%

                      • 1.45

                      • Invesco PowerShares Capital Mgmt LLC

                      •  

                        8,455,447

                      • -6.09%

                      • 1.11

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Slow Growth

                      Style

                      Large Growth

                      Amgen Inc is a Delaware corporation was incorporated in 1980. The Company is a biotechnology medicines company. It discovers, develops, manufactures and delivers human therapeutics. Its medicines help patients fight against cancer, k...moreidney disease, rheumatoid arthritis (RA), bone disease, and other serious illnesses. The Company operates in one business segment which includes human therapeutics. Its products are Neulasta®, NEUPOGEN®, ENBREL, Aranesp®, EPOGEN®, XGEVA®, Prolia® and Sensipar®/Mimpara®. The products it manufactures include both biologics and small molecule drugs. The majority of its products are biologics which are produced in living systems and are inherently complex due to naturally-occurring molecular variations. In addition to its marketed products, it has various product candidates ...morein mid- to late-stage development in a variety of therapeutic areas, including oncology, hematology, inflammation, bone health, nephrology, cardiovascular and general medicine, which includes neuroscience. The Company competes with other clinical trials for eligible patients, which may limit the number of available patients who meet the criteria for certain clinical trials.lessless

                      Key People

                      Mr. Robert A. Bradway

                      CEO/Chairman of the Board/Director/President

                      David W. Meline

                      Executive VP/CFO

                      Brian Mcnamee

                      Executive VP, Divisional

                      Anthony C. Hooper

                      Executive VP, Divisional

                      Madhu Balachandran

                      Executive VP, Divisional

                      • Amgen Inc

                      • One Amgen Center Drive

                      • Thousand Oaks, CA 91320-1799

                      • USA.Map

                      • Phone: +1 805 447-1000

                      • Fax: +1 805 447-1010

                      • amgen.com

                      Incorporated

                      1980

                      Employees

                      20,000

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: